APPLICATION
ANDA218502
TYPE
ANDA
ORIGINAL APPROVAL
2025-06-26
LATEST ACTION
2025-06-26
ROUTE
ORAL
DOSAGE FORM
FOR SUSPENSION
MARKETING STATUS
Prescription
Products
RIVAROXABANPrescription
RIVAROXABAN 1MG/ML · FOR SUSPENSION · ORAL
Approval history
2025-06-26UNKNOWN · Original · standardAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.